NCT00591656Unknown不适用
A Phase II Study of Systemic Consolidation Therapy With Paclitaxel Plus Carboplatin Following Primary Chemoradiation for Locally Advanced Cervical Cancer
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 69
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine the therapeutic efficacy and complications of systemic consolidation therapy with paclitaxel plus carboplatin following primary chemoradiation for locally advanced cervical cancer.
详细描述
Systemic consolidation therapy with paclitaxel plus carboplatin (3 cycles per 3 weeks) following primary chemoradiation (3 cycles per 3 weeks) for locally advanced cervical cancer will elevate the therapeutic efficacy by removing the microscopic metastatic lesions which could not be identified by naked eye and diagnostic imaging tests.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •patients who underwent three cycles of concurrent chemoradiation therapy with paclitaxel and carboplatin for non-small cell type cervical cancer stage IB2, bulky size (>4cm) IIA,IIB-IVA
- •above 20 years
- •GOG performance status 0-2
- •Informed consent
- •Platelet>100K, Hb> 10.0 g/dl, ANC>1500/mm3, Cr <1.25*upper normal limit, bilirubin<1.5mg/dl, AST & ALT<*3 upper normal limit
- •Expected life > 6 months
排除标准
- •Peripheral neurotoxicity > NCI CTCAE grade 2
- •Sever infection
- •Previous history with chemotherapy or radiation therapy
- •Pleural effusion, pericardial effusion, and ascites which could cause dyspnea > NCI grade 2
- •Paraaortic lymph node metastasis
- •Allergy with platinum
- •Previous history of atrial or ventricular arrhythmia or congestive heart failure
- •Uncontrolled infection, diabetes mellitus, hypertension, ischemic heart disease, myocardiac infarct within 6 months
- •Severe disease such as acute or chronic renal failure and acute cerebral infarct, cerebral hemorrhage, recurrent hepatitis, liver cirrhosis, unknown fever above 39 degrees centigrade
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical CancerCervical CancerNCT00592059Seoul National University Hospital77
已完成
2 期
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxelNon Small Cell Lung CancerNCT02684461UNC Lineberger Comprehensive Cancer Center20
招募中
2 期
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaNeuroblastomaNCT02605421Masonic Cancer Center, University of Minnesota12
尚未招募
2 期
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaOral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell CarcinomaRecurrent Oral and Oropharyngeal Squamous Cell CarcinomaNCT06728618Shanghai Zhongshan Hospital28
尚未招募
不适用
Reconsolidation-Based Intervention for Traumatic MemoriesDepressionNCT06143800Shenzhen Kangning Hospital390